newsfilter
← Latest News
GlobeNewswire·

Ensysce Biosciences Receives Investigational New Drug Allowance for its Unique PF614-MPAR™ Opioid with Overdose Protection

NEW YORK and SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ("Ensysce") and Leisure Acquisition Corp. ("LACQ") (NASDAQ:LACQ, LACQU, LACQW))), a special purpose acquisition company formed for the purpose of effecting a merger, a